These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6346863)

  • 1. Treatment bias in the management of end-stage renal disease.
    Smith MD; Hong BA; Michelman JE; Robson AM
    Am J Kidney Dis; 1983 Jul; 3(1):21-6. PubMed ID: 6346863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dilemmas of patient treatment for end-stage renal disease.
    Schmidt RW; Blumenkrantz M; Wiegmann TB
    Am J Kidney Dis; 1983 Jul; 3(1):37-47. PubMed ID: 6346866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case-mix and treatment in end-stage renal disease: hemodialysis v peritoneal dialysis.
    Radecki SE; Mendenhall RC; Nissenson AR; Freeman RB; Blagg CR; Capelli JP; Gentile DE; Feinstein EI
    Am J Kidney Dis; 1988 Jan; 11(1):7-14. PubMed ID: 3122560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does social support determine the treatment setting for hemodialysis patients?
    Smith MD; Hong BA; Province MA; Robson AM
    Am J Kidney Dis; 1985 Jan; 5(1):27-31. PubMed ID: 3966466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Geographic access to health care services: the case of maintenance hemodialysis.
    Smith MD; Robson AM; Woodward RS; Michelman JE; Valerius TJ; Hong BA
    Am J Kidney Dis; 1985 Jan; 5(1):19-26. PubMed ID: 3966465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dialysis modality selection among patients attending freestanding dialysis facilities.
    Kendix M
    Health Care Financ Rev; 1997; 18(4):3-21. PubMed ID: 10175611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Home dialysis and dialysis treatment modalities in the VA system.
    Wiegmann TB; Blumenkrantz M; Layard M; Schmidt RW; Shen F; Stead W
    Am J Kidney Dis; 1983 Jul; 3(1):32-6. PubMed ID: 6346865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. For-profit versus not-for-profit dialysis care for children with end stage renal disease.
    Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR
    Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching and the definition of modality in end-stage renal disease treatment.
    Smith DG; Wheeler JR
    Med Care; 1987 Dec; 25(12):1168-78. PubMed ID: 3320593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis.
    Mehrotra R; Marsh D; Vonesh E; Peters V; Nissenson A
    Kidney Int; 2005 Jul; 68(1):378-90. PubMed ID: 15954930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual facility survey of providers of ESRD therapy. United States Renal Data System.
    Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S132-5. PubMed ID: 9713415
    [No Abstract]   [Full Text] [Related]  

  • 12. Providers of ESRD therapy.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):89-92. PubMed ID: 1951361
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of end-stage chronic renal failure in Switzerland].
    Spertini F; Wauters JP
    Schweiz Med Wochenschr; 1985 May; 115(21):722-7. PubMed ID: 3892661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of ESRD treatment: an international study.
    Mattern WD; McGaghie WC; Rigby RJ; Nissenson AR; Dunham CB; Khayrallah MA
    Am J Kidney Dis; 1989 Jun; 13(6):457-64. PubMed ID: 2658559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dialysis facility and network factors associated with low kidney transplantation rates among United States dialysis facilities.
    Patzer RE; Plantinga L; Krisher J; Pastan SO
    Am J Transplant; 2014 Jul; 14(7):1562-72. PubMed ID: 24891272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.
    Brown J; Josephson M
    Adv Ren Replace Ther; 2000 Oct; 7(4 Suppl 1):S85-94. PubMed ID: 11053593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal replacement therapy among disadvantaged populations in Mexico: a report from the Jalisco Dialysis and Transplant Registry (REDTJAL).
    Garcia-Garcia G; Monteon-Ramos JF; Garcia-Bejarano H; Gomez-Navarro B; Reyes IH; Lomeli AM; Palomeque M; Cortes-Sanabria L; Breien-Alcaraz H; Ruiz-Morales NM
    Kidney Int Suppl; 2005 Aug; (97):S58-61. PubMed ID: 16014102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving the care of patients treated with hemodialysis: a report from the Health Care Financing Administration's ESRD Core Indicators Project.
    McClellan WM; Soucie JM; Krisher J; Caruana R; Haley W; Farmer C
    Am J Kidney Dis; 1998 Apr; 31(4):584-92. PubMed ID: 9531173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dialysis facility characteristics and variation in employment rates: a national study.
    Kutner N; Bowles T; Zhang R; Huang Y; Pastan S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):111-6. PubMed ID: 18178781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.